Emily Wright

P749 Crohn’s disease stricture response and resolution with adalimumab therapy demonstrated with intestinal ultrasound. The STRIDENT randomised trial

G Lovett, JD Schulberg, AL Hamilton, EK Wright, TR Sutherland, MA Kamm

Journal article  |  2023  |  Journal of Crohn's and Colitis

Abstract Background Transmural healing is a treatment goal in the management o..

DOP85 Crohn's Disease Strictures Respond to Drug Treatment and Treat-to-Target Intense Combination Therapy is More Effective than Standard Anti-TNF Therapy. Two year results of the STRIDENT Randomised Controlled Trial

J Schulberg, A Hamilton, EK Wright, B Holt, G Lovett, T Sutherland, A Ross, S Vogrin, M Kamm

Journal article  |  2023  |  Journal of Crohn's and Colitis

Abstract Background The randomised STRIDENT (Stricture Definition and Treatmen..

P587 Intestinal ultrasound (IUS) and magnetic resonance imaging (MRI) for monitoring of response to therapy in luminal Crohn’s disease – a systematic review

G Lovett, JD Schulberg, AL Hamilton, HE Wilding, MA Kamm, EK Wright

Journal article  |  2023  |  Journal of Crohn's and Colitis

Abstract Background Mucosal and transmural healing are associated with better ..

P669 Improving Crohn’s disease stricture dilation outcome: Effect of repeated dilation, needle knife stricturotomy, and ongoing active inflammation

JD Schulberg, AL Hamilton, EK Wright, B Holt, T Sutherland, AL Ross, S Vogrin, MA Kamm

Journal article  |  2023  |  Journal of Crohn's and Colitis

Abstract Background Traditionally Crohn’s disease strictures have been treated..

P378 Pharmacokinetics of Vedolizumab and Ustekinumab in pregnant women with Inflammatory Bowel Disease and their infants exposed in-utero

R Prentice, E Flanagan, EK Wright, PR Gibson, S Rosella, O Rosella, R Goldberg, L Prideaux, K Kiburg, AL Ross, M Burns, SJ Bell

Journal article  |  2023  |  Journal of Crohn's and Colitis

Abstract Background The impact of pregnancy on vedolizumab (VDZ) and ustekinum..

Gastrointestinal Involvement of Eosinophilic Granulomatosis with Polyangiitis with Histological Evidence of Treatment Response.

Mark Lai, Tony He, Emily K Wright

Journal article  |  2023  |  Case Rep Gastroenterol

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis of small to medium vessels. Gastrointestinal in..

Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics.

Robert D Little, Mark G Ward, Emily Wright, Asha J Jois, Alex Boussioutas, Georgina L Hold, Peter R Gibson, Miles P Sparrow

Journal article  |  2022  |  J Clin Med

CT-P13 is the first subcutaneous infliximab molecule approved for the management of inflammatory bowel disease (IBD). Compared to ..

Preconception, antenatal and postpartum management of inflammatory bowel disease.

Ralley Prentice, Emily K Wright, Emma Flanagan, Lani Prideaux, Rimma Goldberg, Sally J Bell

Journal article  |  2022  |  Aust J Gen Pract

BACKGROUND: Inflammatory bowel disease (IBD), comprising ulcerative colitis and Crohn's disease, commonly affects individuals of c..

Clinical outcomes amongst elderly patients with inflammatory bowel disease

Vithoosharan Sivanathan, Chamara Basnayake, William Connell, Emily Wright, John Nik Ding, Ola Niewadomski, Annalise Stanley, Amy Wilson-O'Brien, Stephanie Fry, Tamie Samyue, Mark Lust, Emma Flanagan, Alexander J Thompson, Michael A Kamm

Journal article  |  2022  |  INTERNAL MEDICINE JOURNAL

BACKGROUNDS AND AIMS: Inflammatory bowel disease (IBD) affects a growing cohort of elderly patients. Our aim was to compare the qu..

Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis.

Rachit Gupta, Julien D Schulberg, Ola Niewiadomski, Emily K Wright

Journal article  |  2022  |  Autoimmun Rev